Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis
Public ClinicalTrials.gov record NCT00764309. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Study to Evaluate the Safety of Dasatinib in the Treatment of Scleroderma Pulmonary Interstitial Fibrosis
Study identification
- NCT ID
- NCT00764309
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 47 participants
Conditions and interventions
Conditions
Interventions
- dasatinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- May 31, 2010
- Completion
- Mar 31, 2011
- Last update posted
- Feb 28, 2012
2009 – 2011
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona | Scottsdale | Arizona | 85259 | — |
| Ucla Division Of Rheumatology | Los Angeles | California | 90095 | — |
| University Of Connecticut Health Center | Farmington | Connecticut | 06030 | — |
| Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| Northwestern University Feinberg School Of Medicine | Chicago | Illinois | 60611 | — |
| Boston University School Of Medicine | Boston | Massachusetts | 02118 | — |
| University Of Michigan | Ann Arbor | Michigan | 48106 | — |
| West Michigan Rheumatology | Grand Rapids | Michigan | 49546 | — |
| Umdnj Clinical Research Center | New Brunswick | New Jersey | 08903 | — |
| Hospital For Special Surgery | New York | New York | 10021 | — |
| University Of Pittsburgh | Pittsburgh | Pennsylvania | 15261 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02905 | — |
| Medical University Of South Carolina | Charleston | South Carolina | 29425 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00764309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2012 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00764309 live on ClinicalTrials.gov.